Steven E. Nissen, MD, MACC

General Statement of Disclosure:

RESEARCH/RESEARCH GRANTS: Eli Lilly(SIGNIFICANT), Amgen(SIGNIFICANT), Astra Zeneca(SIGNIFICANT), Esperion Therapeutics(SIGNIFICANT), Novartis(SIGNIFICANT), Novo Nordisk(NONE), Orexigen(SIGNIFICANT), Pfizer(SIGNIFICANT), Resverlogix(SIGNIFICANT), Takeda(SIGNIFICANT), The Medicines Company(SIGNIFICANT), AbbVie, Inc.(SIGNIFICANT), Medtronic(NONE)

View Full Disclosure